chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got the shot Oct 22, 2014 for 5 days and present day shortness of breath. Arm on left side where shot given swell twice the size turned beet red and severe pain and immobile. Still have pain some today.
Patient received herpes zoster vaccine and had a fever spike two hours later. Acetaminophen 650 mg PRN.
Pt recvd vax 14APR92 & lab eval on 1JUL92 revealed anti-HBs of 71.1; 6AUG92 exp joint pain in rt deltoid shoulder area w/dec ROM & dec strength; pt exp painw/horizontal adduction; seen by MD; PE revealed sl rt deltoid atrophy;
Felt exactly like when I had covid Fever 101.8 Headache, Body aches, Neck soreness,  Fatigue
pt recvd vax; exp fever & local rxn; 19apr93 f/u: recovered;
8/28/09 Was shaking and off balance "dizzy" after shots.  Noted all the way to bedtime - didn't stop - Then 8/26/09 had febrile symptoms - Went to ER.
Information has been received from a nurse concerning a 82 old female patient with unspecified drug reactions/allergies and medical history who was vaccinated with a dose of ZOSTAVAX (Merck) (date, dose, route and lot number not reported).  There was no concomitant medication.  The nurse reported as she was administering the vaccine to a patient "part of medication leaked out of the syringe and dripped on the patient's arm".  The nurse also stated "the patient reported the medication burned as it was injected into her arm".  The patient was recovered.  The patient sought medical attention, she spoke with nurse.  Additional information has been requested.
Nausea, Fever 8:00PM Projectile vomiting, intense headache, chills, sweats 8/21/2010 4:00AM stomach pain going away, chills and sweats subsiding, headache still intense 9:30 AM - ate soup 12 Noon - returned to work with headache
pt recvd vax; t 104 w/in 24 hrs of vax; adenopathy at inject site;
Extreme fatigue  Fainting Headache Muscle aches Severe bone pain Nausea Loss of appetite Increased heart rate Injection site pain - inability to use left arm Chills - could not get warm Excessive sleep Increased temp. Day out of work.  Required assistance to get myself up from laying or sitting down, due to the increased severe pain of muscles and bones.  Difficulty walking or standing. Increased respirations. Self treated at home with Theraflu.  Theraflu took the edge off the headache, no effect for bone and muscle pains.  Bone and muscle pain remained consistent. Fatigue and malaise
A non-serious spontaneous report of FluMist administered to 14 month old was received from a Licensed practical nurse concerning a 14-month-old male patient. The patient's medical history and concomitant medications were not reported. The patient received FluMist on 19-Nov-2009. There was no adverse event associated with this vaccination error; therefore, treatment and reporter/sponser causality assessments are not applicable and the event is considered resolved. This case is submitted in accordance with Medimmune's post-marketing commitment on accelerated reporting for the newly indicated population of 2 years to 59 months of age for FluMist.
Post vax, had local swelling at injection site with slight light-headedness. Given Benadryl 25mg and observed for 30 minutes. Also, used ice pack.
Shortly after receiving 2nd dose, he started sweating; He started with stomach cramps within 2 hours; diarrhea within 2 hours; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-Apr-2021 and was forwarded to Moderna on 28-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Shortly after receiving 2nd dose, he started sweating), ABDOMINAL PAIN UPPER (He started with stomach cramps within 2 hours) and DIARRHOEA (diarrhea within 2 hours) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included Sleep medicine for an unknown indication.   On 27-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, the patient experienced HYPERHIDROSIS (Shortly after receiving 2nd dose, he started sweating), ABDOMINAL PAIN UPPER (He started with stomach cramps within 2 hours) and DIARRHOEA (diarrhea within 2 hours). At the time of the report, HYPERHIDROSIS (Shortly after receiving 2nd dose, he started sweating), ABDOMINAL PAIN UPPER (He started with stomach cramps within 2 hours) and DIARRHOEA (diarrhea within 2 hours) outcome was unknown. Not Provided          No laboratory was not given.   Patient was still experienced stomach cramps, diarrhea,sweating  No treatment information was not given.
NEEDLE WAS NOT TIGHTENED ONTO SYRINGE AND PART OF VACCINE SERUM LEAKED OUT DURING ADMINISTRATION
FEELING VERY HOT; NUMB TONGUE; SHAKING; FEELING UNWELL; CHILLS/SHIVERING; FEVER; EXHAUSTION; This spontaneous report received from a parent concerned a 23 year old female. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 08-APR-2021, the subject experienced feeling very hot. On 08-APR-2021, the subject experienced numb tongue. On 08-APR-2021, the subject experienced shaking. On 08-APR-2021, the subject experienced feeling unwell. On 08-APR-2021, the subject experienced chills/shivering. On 08-APR-2021, the subject experienced fever. On 08-APR-2021, the subject experienced exhaustion. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, chills/shivering, exhaustion, numb tongue, feeling unwell, feeling very hot, and shaking. This report was non-serious.
Pain and swelling at injection site, fever, pale, weakness, increased HR, dizzy, thirsty.
Red, hot area rt gluteus. Given DPT in site 5May92, 4" area cellulitus. WMC. APAP. Amox 250 X 10 days
Appearance of classic chickenpox rash yesterday, was told to stay at home and not come to school for a week.
11JUL96 fever 101 lasted till 13JUL96 PM, irritable, fussy, cold-like sx;13JUL96 1030PM no fever pt was sleeping mom noticed stiffness of arms & legs, shaking of whole body x 30sec;pt was unresponsive to stimuli;p/this episode pt fell aslee
Information has been received regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. In June 2014, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), administered at a pharmacy, as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On or about 01-MAY-2015, the patient was treated by a physician for symptoms of a blistering vesicular outbreak which was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX, and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, and as a result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events is unknown. Additional information has been requested.
Instant right fingertips numbness,  Breast itch and have for days, the numbness in fingertips have not gone away. Shortness of breathe on and off. Headache the evening and next day after the shot.
Patient had a fainting episode after vaccination. Patient was observed sitting on the floor. Patient was given water and observed and blood pressure was taken and was adequate. After a few minutes patient felt better and the patient's mother took her home. I called the father later in the evening and he stated the patient was now fine, had eaten something and doing well.
2/3/04 12:15 developed puritic, erythemous rash rapid development to bullous lesions on hands. Benadryl 50gm IM at 1515. In ED 1800 rash flat red on forearms, abdomen and inner thigh. Some bloody in appearance with min. drainage on hands. 2/4/00 0800-4 bullous-bloody lesion on hands-none elsewhere. The hospital discharge summary received on 2/17/04 states pt was in hospital less than 24 hrs and was treated with Benadryl for rash. Final diagnosis is left blank, but MD states lesions were probably a result of a vaccine reaction, though she is uncertain if it was the smallpox or anthrax vaccine.
Diarrhea followed by shivering, muscle spasms, felt very cold, fever.  Could not get warm.
The day following vaccination, the patient developed soreness in arm and tenderness which still persists. She has limited use of her arm due to the pain.
Resident ate a few small bites of pudding then refused.  Resident then began with white, foul smelling emesis. Resident noted to be hunched over and clutching chest, unable to verbalize discomfort. BP 155/118 (manual) P 87 T 98.1 R 20. Out via  911 immediately.
First weird thing is I suddenly felt very sad and depressed and was uncontrollably flipping from crying to laughing like a crazy person! So it was definitely messing with my emotions. I took NyQuil after that to knock myself out lol. Second thing is the next day I suddenly developed a weird mark on my lower lip and they were kinda swollen too. The mark was a dark color that looked like a line. I have a picture
Fever; headaches; muscle aches; fatigue; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), HEADACHE (headaches), MYALGIA (muscle aches), FATIGUE (fatigue) and CHILLS (Chills) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A20A) for COVID-19 vaccination.     No Medical History information was reported.  On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced PYREXIA (Fever), HEADACHE (headaches), MYALGIA (muscle aches), FATIGUE (fatigue) and CHILLS (Chills). On 26-Feb-2021, PYREXIA (Fever), HEADACHE (headaches), MYALGIA (muscle aches), FATIGUE (fatigue) and CHILLS (Chills) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No Concomitant medicines provided  No Treatment medicines provided   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Email address provided, spelling of last name corrected.
Leg swollen, red and warm to the touch a few hours after injection.  (The whole thigh).  Temperature 99-100.9, mild induration - mild erythema.
Severe fatigue, flu-like symptoms, vertigo, lightheadedness, nausea
SICKNESS; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 08-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced sickness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sickness was not reported. This report was non-serious.
extremely weak; Dizziness/dizzy; restless night and slept very little; low-grade fever/temperature; Fell down; This is a spontaneous report from a contactable consumer (patient's husband). A 73-year-old female patient received bnt162b2 (PFIZER BIONTECH COVID 19 VACCINE, solution for injection, lot number: EN6207 and expiration date: 30Jul2021) administered on right arm on 29Mar2021 12:15 PM (at age of 73 years) as dose 2, single for Covid-19 immunization. Medical history included Covid in Jul2020. Patient did not take any other vaccinations with in four weeks prior to the first administration date of the suspect vaccine. The concomitant medication included mecobalamin (B12) shot in Mar2021. The historical vaccine included first dose of bnt162b2 (PFIZER BIONTECH COVID 19 VACCINE, lot number: EN6206 and expiration date: 30Jun2021) administered in the left arm as a single dose at 12:15 on an unknown date (at age of 73 years) for Covid-19 immunization. Consumer reported that his wife received the 2nd dose of the Pfizer Covid19 Vaccine yesterday (29Mar2021) at 12:15 pm and had no immediate reactions. Last night his wife had a restless night and slept very little and had a low-grade fever/temperature. Today, on 30Mar2021 his wife was extremely weak and dizziness/dizzy. Patient also experienced fell down on an unknown date in 2021. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Patient completed Moderna COVID-19 vaccination on 3/1/21. Lot number is not specified in the medical records. Patient was admitted to reporting hospital on 9/12/21 after complaints of shortness of breath and fever. Pt was found to be COVID positive the day prior at her resident facility. EMS was activated due to worsening symptoms and a pulse ox of 91%.  Admitting PCR test for COVID-19 was positive on 9/12/21. Patient was discharged on 9/15/21, but then later readmitted on 9/16/21. She is currently admitted.
Experience shingles outbreak starting May 12.; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 30Apr2021 at 14:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included shingles in 2018, sulfonamide allergy and allergies to several contract dyes. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. The patient previously received acetaminophen (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. The patient previously received SHINGRIX vaccine for shingles both doses by Aug2019.The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 09Apr2021 at 14:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021 at 08:00, the patient experienced shingles outbreak. The patient previously had shingles in 2018 and recovered in a few weeks. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with valacyclovir HCL (MANUFACTURER UNKNOWN) 1-gram tablets. The clinical outcome of the event shingles was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
This is a spontaneous report from a contactable physician (patient's parent). An 18-year-old female patient of an unspecified ethnicity received the second dose of TRUMENBA, via an unspecified route of administration on 17Nov2017 at single dose for immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced injection site reaction five inches by three inches in size, with redness, induration, and warmth to touch. The physician inquired if should be concerned about such a large and severe reaction. Outcome of the events was unknown. Information on lot number and expiration date of the vaccine has been requested.
Pt received vaccine at 1414. 1430 pt started getting dizzy, b/p 142/70, p-81, 02 98%ra, r-18. 1441reports a little dizzy and now feels very tired would like to lie down and sleep. 1446 dizziness resolved cont to be tired. 1456 b/p 158/78, p-75, r-18, 02 sat 98% ra reports tired but no other issues. Instructed to follow up with MD as needed. Pt released with husband
She reported having an abnormally sore arm within hours of receving the vaccine. It was hot to the touch, but she did not have a fever. She felt like her lips were swollen, and her tongue very slightly numb and "coated." Within 48 hours the soreness has subsided, and her lips were no longer swollen. She was still experiencing the "coated" tongue.
measles rash, fever devel on 14MAY;pt informed pt was having a measles rxn to MMR shot;
Symptoms started with tingling sensation and itching of lips on Sunday, Feb. 14th. Sores on upper and lower lip and in mouth developed in the same day. Fever, chills, and fatigue started on Saturday, Feb. 13th. Swelling of lips, sores, and fatigue still present on Tuesday, Feb 16th. Has taken tylenol for fever; no other medications taken. Seen by doctor for symptoms on Tuesday, Feb. 16th.
Report received from a consumer on 28-SEP-2010 (received via Merck WAES: 1009USA05339). A male patient (date of birth: unknown) received a dose of AFLURIA (batch number: M52108, expiry date: 30-JUN-2011) via intramuscular injection for influenza virus vaccination on 23-SEP-2010. The patient's medical history and concomitant medication was not specified. On 24-SEP-2010, the day after receiving the suspect drug AFLURIA, the patient developed a fever, chills and frequent urination. The patient had not sought medical attention. The patient's outcome was not specified at the time of reporting. No further information was provided. The case was reported as non-serious. The reporter did not provide a causality assessment in relation to the suspect drug, AFLURIA. The company considered events possible in relation to the suspect drug, AFLURIA. Information derived from this AE report does not change the current safety profile of the product.
suspected vaccination failure; I still get them .have a couple of patches now on.my back; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (getting them since early teens) and shingles (Family History) (grandmother).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by the patient himself/ herself. The age at vaccination was not reported. The patient took care of grandmother all summer who had them.  This was in the days without gloves and masks. The patient got the shingle shot and still got shingles. At the time of reporting, the patient had a couple of patches on back.  They were milder with the shot but on some not gone. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
About 30 minutes after vaccination, I was driving and I got a really bad hot flash, I tasted metal in my mouth, my heart rate spiked up to 140, my throat and tongue were tingly, it felt like a cardiac event or panic attack. Throughout the day it happened about 3-5 times during the day. I was afraid to drive. This happened a few times in the next few days.
Significant and persistent pain in neck area / upper spine; Significant and persistent pain in neck area / upper spine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 40 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 20Mar2021 01:45 (Batch/Lot number: unknown) at the age of 40 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NECK PAIN (non-serious), SPINAL PAIN (non-serious) all with onset Mar2021, outcome "unknown" and all described as "Significant and persistent pain in neck area / upper spine". The event "significant and persistent pain in neck area / upper spine" and "significant and persistent pain in neck area / upper spine" was evaluated at the physician office visit. It was unknown if therapeutic measures were taken as a result of neck pain, spinal pain.  Additional information: Pfizer had permission to contact reporter about this report. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. Patient received other medications within 2 weeks of vaccination but reporter stated, please ask the individual themselves. Patient had not been diagnosed with COVID-19 prior to vaccination and it was unknown if the patient was tested for COVID-19 since the vaccination. It was unknown if the patient had allergies to medications, food, or other products.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
After receiving COVID vaccine around 1720 and being observed post vaccination pt returned at 1807 to observation area with complaints of feeling anxious, pt noted to have flushed face and sweating.   BP was 160/88 and HR 108, pt observed for additional time flushing and sweating resolved, pts BP and HR decreased to 137/73 and 73.   Pt declined further evaluation in ED
Symptoms started 11/7/21 "felt like she was on fire", did not have fever, body aches, cough, runny nose. Current symptoms: "stuffy head", body aches, runny nose.